Atria Wealth Solutions, Inc. Gilead Sciences, Inc. Transaction History

Atria Wealth Solutions, Inc.

$8.89 Billion
Q3 2024

A detailed history of Atria Wealth Solutions, Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Atria Wealth Solutions, Inc. holds 61,164 shares of GILD stock, worth $5.66 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

61,164

Previous 74,921 18.36%

Holding current value

$5.66 Million

Previous $5.14 Million 0.27%

% of portfolio

0.06%

Previous 0.06%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$66.59 - $83.99 $916,078 - $1.16 Million	-13,757 Reduced 18.36%	61,164 $5.13 Million
Q2 2024 Jul 22, 2024	SELL	$63.15 - $72.88 $47,425 - $54,732	-751 Reduced 0.99%	74,921 $5.14 Million
Q1 2024 May 13, 2024	SELL	$71.58 - $87.29 $345,230 - $420,999	-4,823 Reduced 5.99%	75,672 $5.54 Million
Q4 2023 Feb 02, 2024	BUY	$73.27 - $83.09 $24,765 - $28,084	338 Added 0.42%	80,495 $6.52 Million
Q3 2023 Nov 08, 2023	BUY	$73.94 - $80.67 $15,305 - $16,698	207 Added 0.26%	80,157 $6.01 Million
Q2 2023 Aug 03, 2023	SELL	$76.01 - $86.7 $903,606 - $1.03 Million	-11,888 Reduced 12.94%	79,950 $6.16 Million
Q1 2023 Aug 22, 2023	BUY	$77.31 - $88.08 $636,493 - $725,162	8,233 Added 10.3%	88,183 $7.32 Million
Q1 2023 Jun 14, 2023	BUY	$77.31 - $88.08 $282,568 - $321,932	3,655 Added 4.14%	91,838 $7.62 Million
Q1 2023 May 10, 2023	SELL	$77.31 - $88.08 $358,486 - $408,426	-4,637 Reduced 5.0%	88,183 $7.32 Million
Q4 2022 Aug 30, 2023	BUY	$62.32 - $89.47 $740,860 - $1.06 Million	11,888 Added 14.87%	91,838 $7.88 Million
Q4 2022 Feb 13, 2023	BUY	$62.32 - $89.47 $223,167 - $320,392	3,581 Added 4.01%	92,820 $7.97 Million
Q3 2022 Feb 13, 2023	SELL	$59.54 - $68.01 $587,540 - $671,122	-9,868 Reduced 9.96%	89,239 $5.51 Million
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $2.19 Million - $2.51 Million	36,862 Added 59.22%	99,107 $6.12 Million
Q2 2022 Aug 15, 2022	SELL	$57.72 - $65.01 $1.27 Million - $1.43 Million	-22,003 Reduced 26.12%	62,245 $3.85 Million
Q1 2022 May 16, 2022	BUY	$57.92 - $72.58 $4.88 Million - $6.11 Million	84,248 New	84,248 $5.01 Million

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

992M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Atria Wealth Solutions, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Atria Wealth Solutions, Inc. with notifications on news.

Account

Atria Wealth Solutions, Inc. Gilead Sciences, Inc. Transaction History